Urinary KIM-1 can be used to differentiate patients with acute tubular necrosis from those with non-acute tubular necrosis, and measuring uKIM-1 levels in patients without AKI can serve as a marker of early kidney injury and predict adverse clinical outcomes, such as dialysis requirements and mortality (Kashani et al., 2017). Here, HAVCR1 is linked to acute kidney injury.